Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 451 entries
Sorted by: Best Match Show Resources per page
Trial finds that omapatrilat is more effective than enalapril for reducing hypertension.

Evidence-based cardiovascular medicine

[No authors listed]
PMID: 16379910
Evid Based Cardiovasc Med. 2004 Jun;8(2):117-8; discussion 119-20. doi: 10.1016/j.ebcm.2004.03.003.

No abstract available.

Cite
Trial finds that omapatrilat is more effective than enalapril for reducing hypertension. Evid Based Cardiovasc Med. 2004;8(2):117-8; discussion 119-20doi: 10.1016/j.ebcm.2004.03.003.
(2004). Trial finds that omapatrilat is more effective than enalapril for reducing hypertension. Evidence-based cardiovascular medicine, 8(2), 117-8; discussion 119-20. https://doi.org/10.1016/j.ebcm.2004.03.003
"Trial finds that omapatrilat is more effective than enalapril for reducing hypertension." Evidence-based cardiovascular medicine vol. 8,2 (2004): 117-8; discussion 119-20. doi: https://doi.org/10.1016/j.ebcm.2004.03.003
Trial finds that omapatrilat is more effective than enalapril for reducing hypertension. Evid Based Cardiovasc Med. 2004 Jun;8(2):117-8; discussion 119-20. doi: 10.1016/j.ebcm.2004.03.003. PMID: 16379910.
Copy Download .nbib Format: NLM
Comparison of the effects of imidapril and enalapril in a prospective, multicentric randomized trial in dogs with naturally acquired heart failure.

Journal of veterinary cardiology : the official journal of the European Society of Veterinary Cardiology

Amberger C, Chetboul V, Bomassi E, Rougier S, Woehrlé F, Thoulon F.
PMID: 19083305
J Vet Cardiol. 2004 Nov;6(2):9-16. doi: 10.1016/S1760-2734(06)70053-4.

OBJECTIVE: To compare the efficacy and tolerability of the long-term administration of two different angiotensin-converting enzyme inhibitors, imidapril and enalapril, in a multicentric, prospective, randomized parallel-group scheme clinical trial in dogs with naturally acquired heart disease.ANIMALS: One hundred twenty...

Cite
Amberger C, Chetboul V, Bomassi E, et al. Comparison of the effects of imidapril and enalapril in a prospective, multicentric randomized trial in dogs with naturally acquired heart failure. J Vet Cardiol. 2004;6(2):9-16doi: 10.1016/S1760-2734(06)70053-4.
Amberger, C., Chetboul, V., Bomassi, E., Rougier, S., Woehrlé, F., Thoulon, F. (2004). Comparison of the effects of imidapril and enalapril in a prospective, multicentric randomized trial in dogs with naturally acquired heart failure. Journal of veterinary cardiology : the official journal of the European Society of Veterinary Cardiology, 6(2), 9-16. https://doi.org/10.1016/S1760-2734(06)70053-4
Amberger, Chris, et al. "Comparison of the effects of imidapril and enalapril in a prospective, multicentric randomized trial in dogs with naturally acquired heart failure." Journal of veterinary cardiology : the official journal of the European Society of Veterinary Cardiology vol. 6,2 (2004): 9-16. doi: https://doi.org/10.1016/S1760-2734(06)70053-4
Amberger C, Chetboul V, Bomassi E, Rougier S, Woehrlé F, Thoulon F. Comparison of the effects of imidapril and enalapril in a prospective, multicentric randomized trial in dogs with naturally acquired heart failure. J Vet Cardiol. 2004 Nov;6(2):9-16. doi: 10.1016/S1760-2734(06)70053-4. PMID: 19083305.
Copy Download .nbib Format: NLM
Bisoprolol in the treatment of chronic heart failure: from pathophysiology to clinical pharmacology and trial results.

Therapeutics and clinical risk management

Metra M, Nodari S, Bordonali T, Milani P, Lombardi C, Bugatti S, Fontanella B, Verzura G, Danesi R, Dei Cas L.
PMID: 18472978
Ther Clin Risk Manag. 2007 Aug;3(4):569-78.

Clinical trials have consistently shown the benefits of beta-blocker treatment in patients with chronic heart failure (HF). As a result, bisoprolol, carvedilol, and metoprolol succinate are now indicated for the treatment of all patients with chronic HF who do...

Cite
Metra M, Nodari S, Bordonali T, et al. Bisoprolol in the treatment of chronic heart failure: from pathophysiology to clinical pharmacology and trial results. Ther Clin Risk Manag. 2007;3(4):569-78
Metra, M., Nodari, S., Bordonali, T., Milani, P., Lombardi, C., Bugatti, S., Fontanella, B., Verzura, G., Danesi, R., & Dei Cas, L. (2007). Bisoprolol in the treatment of chronic heart failure: from pathophysiology to clinical pharmacology and trial results. Therapeutics and clinical risk management, 3(4), 569-78.
Metra, Marco, et al. "Bisoprolol in the treatment of chronic heart failure: from pathophysiology to clinical pharmacology and trial results." Therapeutics and clinical risk management vol. 3,4 (2007): 569-78.
Metra M, Nodari S, Bordonali T, Milani P, Lombardi C, Bugatti S, Fontanella B, Verzura G, Danesi R, Dei Cas L. Bisoprolol in the treatment of chronic heart failure: from pathophysiology to clinical pharmacology and trial results. Ther Clin Risk Manag. 2007 Aug;3(4):569-78. PMID: 18472978; PMCID: PMC2374926.
Copy Download .nbib Format: NLM
The brain Renin-Angiotensin system and the regulation of prolactin secretion in female rats: influence of ovarian hormones.

Journal of neuroendocrinology

Myers LS, Steele MK.
PMID: 19210444
J Neuroendocrinol. 1989 Aug 01;1(4):299-303. doi: 10.1111/j.1365-2826.1989.tb00119.x.

Abstract This study was designed to investigate the effects of exogenous and endogenous angiotensin II (All) on prolactin release in ovariectomized rats, with and without estrogen and progesterone pretreatment. In the first series of experiments, All or vehicle was...

Cite
Myers LS, Steele MK. The brain Renin-Angiotensin system and the regulation of prolactin secretion in female rats: influence of ovarian hormones. J Neuroendocrinol. 1989;1(4):299-303doi: 10.1111/j.1365-2826.1989.tb00119.x.
Myers, L. S., & Steele, M. K. (1989). The brain Renin-Angiotensin system and the regulation of prolactin secretion in female rats: influence of ovarian hormones. Journal of neuroendocrinology, 1(4), 299-303. https://doi.org/10.1111/j.1365-2826.1989.tb00119.x
Myers, L S, and Steele, M K. "The brain Renin-Angiotensin system and the regulation of prolactin secretion in female rats: influence of ovarian hormones." Journal of neuroendocrinology vol. 1,4 (1989): 299-303. doi: https://doi.org/10.1111/j.1365-2826.1989.tb00119.x
Myers LS, Steele MK. The brain Renin-Angiotensin system and the regulation of prolactin secretion in female rats: influence of ovarian hormones. J Neuroendocrinol. 1989 Aug 01;1(4):299-303. doi: 10.1111/j.1365-2826.1989.tb00119.x. PMID: 19210444.
Copy Download .nbib Format: NLM
Treatment of Post-transplant Erythrocytosis with Enalapril.

Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia

Akash N, Smadi I, El-Lozi M.
PMID: 18408290
Saudi J Kidney Dis Transpl. 1998 Apr-Jun;9(2):144-6.

This prospective study was carried out to estimate the efficacy and safety of Enalapril therapy in post-transplant erythrocytosis. Thirteen long-term renal allograft recipients (11 males and two females) with increased hematocrit values (>51%) and elevated red cell mass were...

Cite
Akash N, Smadi I, El-Lozi M. Treatment of Post-transplant Erythrocytosis with Enalapril. Saudi J Kidney Dis Transpl. 1998;9(2):144-6
Akash, N., Smadi, I., & El-Lozi, M. (1998). Treatment of Post-transplant Erythrocytosis with Enalapril. Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia, 9(2), 144-6.
Akash, N, et al. "Treatment of Post-transplant Erythrocytosis with Enalapril." Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia vol. 9,2 (1998): 144-6.
Akash N, Smadi I, El-Lozi M. Treatment of Post-transplant Erythrocytosis with Enalapril. Saudi J Kidney Dis Transpl. 1998 Apr-Jun;9(2):144-6. PMID: 18408290.
Copy Download .nbib Format: NLM
Gateways to clinical trials.

Methods and findings in experimental and clinical pharmacology

Tomillero A, Moral MA.
PMID: 20508873
Methods Find Exp Clin Pharmacol. 2010 May;32(4):247-88. doi: 10.1358/mf.2010.32.4.1507200.

O(6)-Benzylguanine; (-)-Gossypol; Abatacept, AC-2592, Adalimumab, AIDSVAX gp120 B/E, Alemtuzumab, Aliskiren fumarate, ALVAC E120TMG, Ambrisentan, Amlodipine, Anakinra, Aripiprazole, Armodafinil, Atomoxetine hydrochloride, Avotermin; Bevacizumab, BIBW-2992, Bortezomib, Bosentan, Botulinum toxin type B; Canakinumab, CAT-354, Ciclesonide, CMV gB vaccine, Corifollitropin alfa, Daptomycin, Darbepoetin...

Cite
Tomillero A, Moral MA. Gateways to clinical trials. Methods Find Exp Clin Pharmacol. 2010;32(4):247-88doi: 10.1358/mf.2010.32.4.1507200.
Tomillero, A., & Moral, M. A. (2010). Gateways to clinical trials. Methods and findings in experimental and clinical pharmacology, 32(4), 247-88. https://doi.org/10.1358/mf.2010.32.4.1507200
Tomillero, A, and Moral, M A. "Gateways to clinical trials." Methods and findings in experimental and clinical pharmacology vol. 32,4 (2010): 247-88. doi: https://doi.org/10.1358/mf.2010.32.4.1507200
Tomillero A, Moral MA. Gateways to clinical trials. Methods Find Exp Clin Pharmacol. 2010 May;32(4):247-88. doi: 10.1358/mf.2010.32.4.1507200. PMID: 20508873.
Copy Download .nbib Format: NLM
Picture Quiz: A case of mediastinal shift.

Acute medicine

Fahim A.
PMID: 21611591
Acute Med. 2007;6(3):132-3.

An 86 year old woman with a background of hypertension and arthritis presented to our medical assessment unit with 3 weeks history of mild dyspnoea and central chest discomfort. She did not have any past history of respiratory problems....

Cite
Fahim A. Picture Quiz: A case of mediastinal shift. Acute Med. 2007;6(3):132-3
Fahim, A. (2007). Picture Quiz: A case of mediastinal shift. Acute medicine, 6(3), 132-3.
Fahim, Ahmed. "Picture Quiz: A case of mediastinal shift." Acute medicine vol. 6,3 (2007): 132-3.
Fahim A. Picture Quiz: A case of mediastinal shift. Acute Med. 2007;6(3):132-3. PMID: 21611591.
Copy Download .nbib Format: NLM
Angiotensin Converting Enzyme Inhibitor (ACEI)-Induced Acute Renal Failure in Premature Newborns with Congenital Heart Disease.

The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG

Lee GJ, Cohen R, Chang AC, Cleary JP.
PMID: 22477817
J Pediatr Pharmacol Ther. 2010 Oct;15(4):290-6.

We report three cases of angiotensin converting enzyme inhibitor (ACEI) induced nephrotoxicity in preterm infants with congenital heart disease. Patients developed acute renal failure after starting captopril or enalapril at doses commonly prescribed for term neonates. There was no...

Cite
Lee GJ, Cohen R, Chang AC, et al. Angiotensin Converting Enzyme Inhibitor (ACEI)-Induced Acute Renal Failure in Premature Newborns with Congenital Heart Disease. J Pediatr Pharmacol Ther. 2010;15(4):290-6
Lee, G. J., Cohen, R., Chang, A. C., & Cleary, J. P. (2010). Angiotensin Converting Enzyme Inhibitor (ACEI)-Induced Acute Renal Failure in Premature Newborns with Congenital Heart Disease. The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG, 15(4), 290-6.
Lee, Grace J, et al. "Angiotensin Converting Enzyme Inhibitor (ACEI)-Induced Acute Renal Failure in Premature Newborns with Congenital Heart Disease." The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG vol. 15,4 (2010): 290-6.
Lee GJ, Cohen R, Chang AC, Cleary JP. Angiotensin Converting Enzyme Inhibitor (ACEI)-Induced Acute Renal Failure in Premature Newborns with Congenital Heart Disease. J Pediatr Pharmacol Ther. 2010 Oct;15(4):290-6. PMID: 22477817; PMCID: PMC3042267.
Copy Download .nbib Format: NLM
Incidence of adverse events with telmisartan compared with ACE inhibitors: evidence from a pooled analysis of clinical trials.

Patient preference and adherence

Mancia G, Schumacher H.
PMID: 22272064
Patient Prefer Adherence. 2012;6:1-9. doi: 10.2147/PPA.S27939. Epub 2011 Dec 23.

Telmisartan is indicated for the prevention of cardiovascular events in high-risk patients, based on comparable efficacy to the angiotensin-converting enzyme (ACE) inhibitor, ramipril, in the ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial (ONTARGET(®)) trial. However,...

Cite
Mancia G, Schumacher H. Incidence of adverse events with telmisartan compared with ACE inhibitors: evidence from a pooled analysis of clinical trials. Patient Prefer Adherence. 2011;6:1-9doi: 10.2147/PPA.S27939.
Mancia, G., & Schumacher, H. (2012). Incidence of adverse events with telmisartan compared with ACE inhibitors: evidence from a pooled analysis of clinical trials. Patient preference and adherence, 61-9. https://doi.org/10.2147/PPA.S27939
Mancia, Giuseppe, and Schumacher, Helmut. "Incidence of adverse events with telmisartan compared with ACE inhibitors: evidence from a pooled analysis of clinical trials." Patient preference and adherence vol. 6 (2012): 1-9. doi: https://doi.org/10.2147/PPA.S27939
Mancia G, Schumacher H. Incidence of adverse events with telmisartan compared with ACE inhibitors: evidence from a pooled analysis of clinical trials. Patient Prefer Adherence. 2012;6:1-9. doi: 10.2147/PPA.S27939. Epub 2011 Dec 23. PMID: 22272064; PMCID: PMC3262485.
Copy Download .nbib Format: NLM
A case of mitochondrial cardiomyopathy with restrictive transmitral filling pattern.

International medical case reports journal

Otsui K, Inoue N, Tamagawa A, Onishi K.
PMID: 23754918
Int Med Case Rep J. 2012 Apr 13;5:19-22. doi: 10.2147/IMCRJ.S30336. Print 2012.

A 61-year-old diabetic woman with a mitochondrial A3243G mutation was hospitalized for evaluation of breathlessness, general fatigue, and leg edema. Chest radiography revealed cardiomegaly with massive pleural effusion. Serum lactate, pyruvate, and brain natriuretic peptide concentrations were elevated. Transthoracic...

Cite
Otsui K, Inoue N, Tamagawa A, et al. A case of mitochondrial cardiomyopathy with restrictive transmitral filling pattern. Int Med Case Rep J. 2012;5:19-22doi: 10.2147/IMCRJ.S30336.
Otsui, K., Inoue, N., Tamagawa, A., & Onishi, K. (2012). A case of mitochondrial cardiomyopathy with restrictive transmitral filling pattern. International medical case reports journal, 519-22. https://doi.org/10.2147/IMCRJ.S30336
Otsui, Kazunori, et al. "A case of mitochondrial cardiomyopathy with restrictive transmitral filling pattern." International medical case reports journal vol. 5 (2012): 19-22. doi: https://doi.org/10.2147/IMCRJ.S30336
Otsui K, Inoue N, Tamagawa A, Onishi K. A case of mitochondrial cardiomyopathy with restrictive transmitral filling pattern. Int Med Case Rep J. 2012 Apr 13;5:19-22. doi: 10.2147/IMCRJ.S30336. Print 2012. PMID: 23754918; PMCID: PMC3658249.
Copy Download .nbib Format: NLM
Effect of Inhibition of Angiotensin-Converting Enzyme and/or Neutral Endopeptidase on Neuropathy in High-Fat-Fed C57Bl/6J Mice.

Journal of obesity

Coppey L, Lu B, Gerard C, Yorek MA.
PMID: 23056927
J Obes. 2012;2012:326806. doi: 10.1155/2012/326806. Epub 2012 Sep 29.

We have demonstrated that treating diet-induced obese (DIO) mice with the vasopeptidase inhibitor ilepatril improved neural function. Vasopeptidase inhibitors block angiotensin-converting enzyme (ACE) and neutral endopeptidase (NEP) activity. We propose that increased activity of ACE and NEP contributes to...

Cite
Coppey L, Lu B, Gerard C, et al. Effect of Inhibition of Angiotensin-Converting Enzyme and/or Neutral Endopeptidase on Neuropathy in High-Fat-Fed C57Bl/6J Mice. J Obes. 2012;2012:326806doi: 10.1155/2012/326806.
Coppey, L., Lu, B., Gerard, C., & Yorek, M. A. (2012). Effect of Inhibition of Angiotensin-Converting Enzyme and/or Neutral Endopeptidase on Neuropathy in High-Fat-Fed C57Bl/6J Mice. Journal of obesity, 2012326806. https://doi.org/10.1155/2012/326806
Coppey, Lawrence, et al. "Effect of Inhibition of Angiotensin-Converting Enzyme and/or Neutral Endopeptidase on Neuropathy in High-Fat-Fed C57Bl/6J Mice." Journal of obesity vol. 2012 (2012): 326806. doi: https://doi.org/10.1155/2012/326806
Coppey L, Lu B, Gerard C, Yorek MA. Effect of Inhibition of Angiotensin-Converting Enzyme and/or Neutral Endopeptidase on Neuropathy in High-Fat-Fed C57Bl/6J Mice. J Obes. 2012;2012:326806. doi: 10.1155/2012/326806. Epub 2012 Sep 29. PMID: 23056927; PMCID: PMC3465928.
Copy Download .nbib Format: NLM
Clinical trials update from the European Society of Cardiology meeting 2014: PARADIGM-HF, CONFIRM-HF, SIGNIFY, atrial fibrillation, beta-blockers and heart failure, and vagal stimulation in heart failure.

ESC heart failure

Clark AL, Pellicori P.
PMID: 28834633
ESC Heart Fail. 2014 Dec;1(2):82-86. doi: 10.1002/ehf2.12012. Epub 2014 Nov 24.

This article provides an overview of trials relevant to the pathophysiology, prevention, and treatment of heart failure, presented at the European Society of Cardiology meeting held in Barcelona in autumn 2014. Trials reported here include PARADIGM-HF (LCZ696 versus enalapril...

Cite
Clark AL, Pellicori P. Clinical trials update from the European Society of Cardiology meeting 2014: PARADIGM-HF, CONFIRM-HF, SIGNIFY, atrial fibrillation, beta-blockers and heart failure, and vagal stimulation in heart failure. ESC Heart Fail. 2014;1(2):82-86doi: 10.1002/ehf2.12012.
Clark, A. L., & Pellicori, P. (2014). Clinical trials update from the European Society of Cardiology meeting 2014: PARADIGM-HF, CONFIRM-HF, SIGNIFY, atrial fibrillation, beta-blockers and heart failure, and vagal stimulation in heart failure. ESC heart failure, 1(2), 82-86. https://doi.org/10.1002/ehf2.12012
Clark, Andrew L, and Pellicori, Pierpaolo. "Clinical trials update from the European Society of Cardiology meeting 2014: PARADIGM-HF, CONFIRM-HF, SIGNIFY, atrial fibrillation, beta-blockers and heart failure, and vagal stimulation in heart failure." ESC heart failure vol. 1,2 (2014): 82-86. doi: https://doi.org/10.1002/ehf2.12012
Clark AL, Pellicori P. Clinical trials update from the European Society of Cardiology meeting 2014: PARADIGM-HF, CONFIRM-HF, SIGNIFY, atrial fibrillation, beta-blockers and heart failure, and vagal stimulation in heart failure. ESC Heart Fail. 2014 Dec;1(2):82-86. doi: 10.1002/ehf2.12012. Epub 2014 Nov 24. PMID: 28834633.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 451 entries